Bnp Paribas Asset Management Holding S.A. Ultragenyx Pharmaceutical Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $37.3 Billion
- Q1 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 1,150,456 shares of RARE stock, worth $31.5 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,150,456
Previous 958,077
20.08%
Holding current value
$31.5 Million
Previous $40.3 Million
3.35%
% of portfolio
0.11%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
89.4MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$273 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$153 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$114 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$88 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$71.6 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.91B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...